Literature DB >> 9124823

Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.

F Soriano1, P García-Corbeira, C Ponte, R Fernández-Roblas, I Gadea.   

Abstract

The MIC is the main microbiologic parameter used to predict the efficacies of antibiotics. However, it is well known that MICs may vary according to the inoculum size used (inoculum effect), especially with some beta-lactam antibiotics. In order to correlate the pharmacologic and microbiologic properties of some beta-lactams, an experimental model of intraperitoneal infection caused by Escherichia coli in nonneutropenic and neutro-penic mice was developed. The animals were treated with three different doses of either ampicillin, piperacillin, aztreonam, cefazolin, or cefotaxime. The linear regression analysis obtained in our model shows a better correlation between in vitro activity and efficacy when the MICs considered were those obtained with a large inoculum (ca. 1 x 10(8) CFU/ml) instead of the standard inoculum (5 x 10(5) CFU/ml). The correlations for the MICs obtained with the large inoculum were 0.78 for log2 maximum concentration of drug in serum (Cmax)/ MIC, 0.72 the time that the concentrations exceeded the MIC, and 0.79 for log2 area under the serum concentration-time curve (AUC)/MIC at 24 h in nonneutropenic mice. The corresponding values in neutropenic mice, also for the MICs obtained with the large inoculum, were 0.54, 0.68, and 0.64, respectively, at 24 h. A good correlation was also obtained for the same parameters in nonneutropenic mice at 48 h. The values of Cmax, AUC, and the time that the concentrations exceeded the MIC were parallel among the antibiotics studied, and our study confirms that the time that the levels in serum exceed the MIC is a significant parameter determining the efficacies of beta-lactam antibiotics, but the correlation is much better when the MICs obtained with the large inoculum instead of those obtained with the standard (low) inoculum are considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9124823      PMCID: PMC163604     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

Review 2.  Optimal dosage of beta-lactam antibiotics: time above the MIC and inoculum effect.

Authors:  F Soriano
Journal:  J Antimicrob Chemother       Date:  1992-11       Impact factor: 5.790

Review 3.  Inoculum effect.

Authors:  I Brook
Journal:  Rev Infect Dis       Date:  1989 May-Jun

4.  Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.

Authors:  F Soriano; R Edwards; D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Relevance of the inoculum effect of antibiotics in the outcome of experimental infections caused by Escherichia coli.

Authors:  F Soriano; C Ponte; M Santamaría; M Jimenez-Arriero
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

6.  Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.

Authors:  B Vogelman; S Gudmundsson; J Leggett; J Turnidge; S Ebert; W A Craig
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

Review 7.  Role of pharmacokinetics in the outcome of infections.

Authors:  G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

8.  Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b.

Authors:  E A Steinberg; G D Overturf; J Wilkins; L J Baraff; J M Streng; J M Leedom
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

9.  Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.

Authors:  S W Chapman; R T Steigbigel
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

10.  Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis.

Authors:  R J Backes; M S Rouse; N K Henry; J E Geraci; W R Wilson
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

View more
  20 in total

1.  Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.

Authors:  Violeta Rodríguez-Cerrato; Pedro García; Lorena Huelves; Ernesto García; Gema Del Prado; Matilde Gracia; Carmen Ponte; Rubens López; Francisco Soriano
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

2.  Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.

Authors:  Pierre Abgueguen; Esther Azoulay-Dupuis; Violaine Noel; Pierre Moine; Veronique Rieux; Bruno Fantin; Jean-Pierre Bedos
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

3.  Animal pharmacokinetics and interspecies scaling of sordarin derivatives following intravenous administration.

Authors:  P Aviles; A Pateman; R San Roman; M J Guillén; F Gómez De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  [New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation].

Authors:  D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

5.  In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.

Authors:  Mirian Domenech; Ernesto García; Miriam Moscoso
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

6.  Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in mice.

Authors:  Lorna E T Stearne; Steven L Buijk; Johan W Mouton; Inge C Gyssens
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.

Authors:  Sandra Rincón; Jinnethe Reyes; Lina Paola Carvajal; Natalia Rojas; Fabián Cortés; Diana Panesso; Manuel Guzmán; Jeannete Zurita; Javier A Adachi; Barbara E Murray; Esteban C Nannini; Cesar A Arias
Journal:  J Antimicrob Chemother       Date:  2013-06-21       Impact factor: 5.790

Review 8.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

9.  Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixed-infection abscesses.

Authors:  Lorna E T Stearne; Doret van Boxtel; Nicole Lemmens; Wil H F Goessens; Johan W Mouton; Inge C Gyssens
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Daily variations in ceftriaxone pharmacokinetics in rats.

Authors:  M Rebuelto; L Ambros; M Rubio
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.